{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:11:08Z","timestamp":1775553068067,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82121005"],"award-info":[{"award-number":["82121005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273764"],"award-info":[{"award-number":["82273764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011198","name":"State Key Laboratory of Drug Research, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013152","name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejmech.2023.116017","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T02:18:57Z","timestamp":1701742737000},"page":"116017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery and exploration of novel somatostatin receptor subtype 5 (SSTR5) antagonists for the treatment of cholesterol gallstones"],"prefix":"10.1016","volume":"264","author":[{"given":"Fanghui","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-4800","authenticated-orcid":false,"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.116017_bib1","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2023.116017_bib2","first-page":"F1000Res","volume":"vol. 7","author":"Di Ciaula","year":"2018"},{"issue":"31","key":"10.1016\/j.ejmech.2023.116017_bib3","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.3748\/wjg.v19.i31.5029","article-title":"Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed","volume":"19","author":"Guarino","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejmech.2023.116017_bib4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejmech.2023.116017_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","article-title":"Somatostatin receptors: from signaling to clinical practice","volume":"34","author":"Theodoropoulou","year":"2013","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejmech.2023.116017_bib6","first-page":"137","article-title":"Somatostatin and somatostatin receptors","volume":"50","author":"Kumar","year":"2010","journal-title":"Results Probl. Cell Differ."},{"issue":"1","key":"10.1016\/j.ejmech.2023.116017_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00235-9","article-title":"Somatostatin receptors","volume":"1616","author":"M\u00f8ller","year":"2003","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"10.1016\/j.ejmech.2023.116017_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/me.2001-0035","article-title":"Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis","volume":"17","author":"Strowski","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"11","key":"10.1016\/j.ejmech.2023.116017_bib9","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1210\/en.2017-00639","article-title":"Regulation of endogenous (male) rodent GLP-1 secretion and human islet insulin secretion by antagonism of somatostatin receptor 5","volume":"158","author":"Farb","year":"2017","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.ejmech.2023.116017_bib10","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.2174\/0929867324666170619104801","article-title":"Update on the molecular mechanisms underlying the effect of cholecystokinin and cholecystokinin-1 receptor on the formation of cholesterol gallstones","volume":"26","author":"Wang","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.116017_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/labinvest.2014.140","article-title":"Cholesterol gallstone disease: focusing on the role of gallbladder","volume":"95","author":"Chen","year":"2015","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.ejmech.2023.116017_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/gast.1996.v111.pm8780583","article-title":"Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence","volume":"111","author":"Pauletzki","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejmech.2023.116017_bib13","first-page":"80","article-title":"Somatostatinoma syndrome: does a clinical entity exist?","volume":"102","author":"Stacpoole","year":"1983","journal-title":"Acta Endocrinol."},{"issue":"3","key":"10.1016\/j.ejmech.2023.116017_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-112-3-173","article-title":"Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety","volume":"112","author":"Ho","year":"1990","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2023.116017_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2982.2009.01407.x","article-title":"Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice","volume":"22","author":"Kaczmarek","year":"2010","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejmech.2023.116017_bib16","series-title":"SCOHIA Initiates a Phase 1 Study on an SSTR5 Antagonist (SCO-240)","year":"2021"},{"issue":"21","key":"10.1016\/j.ejmech.2023.116017_bib17","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1016\/j.bmcl.2009.09.024","article-title":"Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists","volume":"19","author":"Martin","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"15","key":"10.1016\/j.ejmech.2023.116017_bib18","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1016\/j.bmcl.2010.06.026","article-title":"Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists","volume":"20","author":"Alker","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"15","key":"10.1016\/j.ejmech.2023.116017_bib19","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.bmc.2017.06.007","article-title":"Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus","volume":"25","author":"Hirose","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2023.116017_bib20","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.bmc.2017.06.003","article-title":"Discovery of novel somatostatin receptor subtype 5 (SSTR5) antagonists: pharmacological studies and design to improve pharmacokinetic profiles and human Ether-a-go-go-related gene (hERG) inhibition","volume":"25","author":"Yamasaki","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2023.116017_bib21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/acsmedchemlett.8b00306","article-title":"Optimization of preclinical metabolism for somatostatin receptor subtype 5-selective antagonists","volume":"9","author":"Liu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.ejmech.2023.116017_bib22","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1021\/acsmedchemlett.8b00305","article-title":"Discovery and pharmacology of a novel somatostatin subtype 5 (SSTR5) antagonist: synergy with DPP-4 inhibition","volume":"9","author":"Liu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"25","key":"10.1016\/j.ejmech.2023.116017_bib23","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1021\/jm701143p","article-title":"Discovery of the first nonpeptidic, small-molecule, highly selective somatostatin receptor subtype 5 antagonists: a chemogenomics approach","volume":"50","author":"Martin","year":"2007","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2023.116017_bib24","first-page":"e313","article-title":"Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease","volume":"24","author":"Lavoie","year":"2012","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"3","key":"10.1016\/j.ejmech.2023.116017_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(05)80324-1","article-title":"Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation","volume":"21","author":"Portincasa","year":"1994","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ejmech.2023.116017_bib26","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/0016-5085(95)90153-1","article-title":"Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstones","volume":"108","author":"Stolk","year":"1995","journal-title":"Gastroenterology"},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2023.116017_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(92)90158-L","article-title":"Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects","volume":"14","author":"van Erpecum","year":"1992","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ejmech.2023.116017_bib28","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/hep.22204","article-title":"Coordinate regulation of gallbladder motor function in the gut-liver axis","volume":"47","author":"Portincasa","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejmech.2023.116017_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOG.0000000000000417","article-title":"Mouse models of gallstone disease","volume":"34","author":"Wang","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ejmech.2023.116017_bib30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.25604","article-title":"Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation?","volume":"55","author":"Portincasa","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ejmech.2023.116017_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/eci.12058","article-title":"Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol","volume":"43","author":"Wang","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ejmech.2023.116017_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/j.gastro.2008.12.031","article-title":"Roles of infection, inflammation, and the immune system in cholesterol gallstone formation","volume":"136","author":"Maurer","year":"2009","journal-title":"Gastroenterology"},{"issue":"19\u201320","key":"10.1016\/j.ejmech.2023.116017_bib33","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.cca.2012.06.015","article-title":"Mucin genes in gallstone disease","volume":"413","author":"Chuang","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ejmech.2023.116017_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease","volume":"34","author":"Di Ciaula","year":"2018","journal-title":"Curr. Opin. Gastroenterol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:01:17Z","timestamp":1759330877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423009844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["S0223523423009844"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116017","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and exploration of novel somatostatin receptor subtype 5 (SSTR5) antagonists for the treatment of cholesterol gallstones","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116017"}}